OR WAIT null SECS
© 2023 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2023 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
April 27, 2023
While ESG is still in the early stages for pharma, many companies are moving forward with a need for compliance.
February 09, 2023
Examining efforts to boost women representation on company boards.
November 08, 2022
The validity of ESG-driven investment and reporting in healthcare.
October 11, 2022
Reaching new heights in sustainability a win-win for industry.
Pharma supply chains are no longer hidden beyond the reach of ESG agendas, making it important for companies to accelerate adoption of new manufacturing processes and environmental technology.
September 09, 2022
A prime opportunity for pharma to raise its strategic game in ESG.
September 06, 2022
Adam Carter discusses the causes and potential solutions to the pharma industry's sustainability issues.
August 17, 2022
How pharma companies can make sure their corporate strategy in ESG is appealing to younger generations—and aligns with the issues this large segment of sustainability investors care about most.
August 10, 2022
How principles of both can help companies navigate future storms.
June 09, 2022
Outlining the most important sustainability-related hurdles facing leading biopharma companies today—and current efforts underway to meet
new expectations in advancing this strategic mandate.